McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with E...( FORT WASHINGTON Pa. Nov. 6 /- ...),Health

FORT WASHINGTON, Pa., Nov. 6 /PRNewswire/ -- In consultation with the U.S. Food and Drug Administration (FDA), McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., is initiating a voluntary recall of a limited number of product lots of TYLENOL® Arthritis Pain Caplet 100 count bottles, with the distinctive red EZ-OPEN CAP. McNeil is initiating the recall after identifying an uncharacteristic smell or taste associated with these lots that led to a small number of consumers reporting nausea and related symptoms. This recall includes five product lots only (Full list of lot numbers provided below), and does not include any other lots of TYLENOL® Arthritis Pain Caplet 100 count with EZ-OPEN CAP or any other TYLENOL® Arthritis Pain products. McNeil is implementing this recall as a precaution.

Consumers who purchased TYLENOL® Arthritis Pain Caplet 100 count bottles with the distinctive red EZ-OPEN CAP from the lots included in this recall should stop using the product and contact McNeil for instructions on a refund or replacement. For these instructions or information regarding how to return or dispose of the product, consumers should call 1-888-222-6036 (Monday-Friday 8 a.m. to 8 p.m. Eastern Time, and Saturday-Sunday 9 a.m. to 5 p.m. Eastern Time) or log on to the internet at www.tylenol.com. Consumers who have medical concerns or questions should contact their healthcare provider.

The affected TYLENOL® Arthritis Pain Caplet 100 count product lot numbers can be found on the side of the bottle label. See the full list of affected product lot numbers below:

Recalled Product- Full List (LINK: http://www.tylenol.com/page2.jhtml?id=tylenol/news/subp_news.inc)

       UPC #       Code #           Lot #             P
'/>"/>
SOURCE  McNeil Consumer Healthcare
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 
Related medicine technology :

1. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
2. Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568
3. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health, First-Ever Leading Calcium Supplement to Help Support Bone AND Heart Health
4. Consumer Reports Health: Americans With Heartburn Paying Too Much Green For Nexiums Purple Pill
5. WebMD Launches New Consumer Health Portal in the U.K.
6. comScore Study Finds the Internet a Key Component in Consumer Research on Prescriptions and Health Conditions
7. IncentOne Introduces Next Generation of Healthy Choice Award(TM) Incentive Solution to Drive Consumer and Provider Engagement
8. New Federal Stem Cell Rules Would Hinder Existing Research, Consumer Group Warns
9. Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
10. Consumer Group Urges Gov. Schwarzenegger to Sign Stem Cell Bill Into Law
11. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Lebanon County Dairy